Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation

Yansi Xian(Guangxi Medical University), Fangming Song(Guangxi Medical University), Yuangang Su(Guangxi Medical University), Jiamin Liang(Guangxi Medical University), Jiake Xu(Guangxi Medical University), Yu Xiao(Guangxi University), Haoyu Lian(Guangxi Medical University), Qian Liu(Guangxi Medical University), Jinmin Zhao(Guangxi Medical University), Xiaoliang Feng(Guangxi Medical University), Feng Long(Renmin University of China)
Biochemical Pharmacology
September 4, 2021
Cited by 91


Related Papers